A significant breakthrough in cancer research is emerging with the use of mini-antibodies to reactivate damaged p53. This vital malignant suppressor protein is frequently inactivated in various forms of cancer, https://checkbookmarks.com/story7669459/nanobodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-malignant-therapy